June 30, 2017

Breaking News

New therapies for blood disease discussed at conference

Myanmar Medical Association President Professor Rai Mra delivers a speech at the conference. Photo: Khaing Thanda Lwin
Myanmar Medical Association President Professor Rai Mra delivers a speech at the conference. Photo: Khaing Thanda Lwin

The Myanmar Society of Haematology kicked off its two-day conference at the Novotel Hotel in Yangon on Saturday.
Professors from Myanmar, the UK, US, India, Japan, Singapore and Thailand gathered to share their knowledge and experience on the latest therapies for blood diseases such as thalassaemia, haemophilia and leukaemia.
The conference was sponsored by the Myanmar Medical Association (MMA), a non-government organisation established in 1949. The association holds similar conferences every two years.
In his opening remarks, Union Health Minister Dr Than Aung affirmed the ministry’s commitment to amending the 2003 Blood and Blood Products Law, stressing that the change will aim to offer high-quality medical care to patients with blood diseases.
The president of the Myanmar Medical Association, Professor Rai Mra, said he was unable to provide figures on patients with blood disorders, but he estimated that there are millions across the country.
“There are many types of blood disorders, among which iron-deficiency anaemia and thalassaemia are the most common.”
Iron-deficiency anaemia occurs when the body does not have enough iron, which results in decreased production of red blood cells.
Thalassemia is a genetic disorder in which the body cannot produce red blood cells, resulting in severe anaemia. It is caused by mutated haemoglobin genes.
On the first day of the conference, doctors discussed developments in thalassaemia research, while the second half of the conference focused on haemophilia management and leukaemia.—GNLM

Comments

Related posts

Translate »